Advertisement.

AVMXY Projected Dividend Yield

Avita Medical Ltd ( OTCBB : AVMXY )

Avita Medical is engaged in the commercialisation of its regenerative product. Co. develops and distributes regenerative products for the treatment of a range of wounds, scars and skin defects. Co.'s patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin. Co.'s primary product, ReCellÂ®, is used in the treatment of a variety of burns, plastic, reconstructive and cosmetic procedures. ReCellÂ® is patented, CE-marked for Europe, TGA-registered in Australia, and CFDA-cleared in China. In the U.S., ReCellÂ® is an investigational device limited by federal law to investigational use, and a pivotal U.S. approval trial is underway.

21 YEAR PERFORMANCE RESULTS

AVMXY Dividend History Detail
AVMXY Dividend News
AVMXY Competitors News

# of Shares: 0

Closing Price: 7.89

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000